Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective

2012 ◽  
Vol 13 (1) ◽  
pp. 21-37 ◽  
Author(s):  
Gourapura J. Renukaradhya ◽  
Varun Dwivedi ◽  
Cordelia Manickam ◽  
Basavaraj Binjawadagi ◽  
David Benfield

AbstractPorcine reproductive and respiratory syndrome (PRRS) is an economically important infectious disease of swine. Constant emergence of variant strains of PRRS virus (PPRSV) and virus-mediated immune evasion followed by viral persistence result in increased incidence and recurrence of PRRS in swine herds. Current live and killed PRRSV vaccines administered by a parenteral route are ineffective in inducing complete protection. Thus, new approaches in design and delivery of PRRSV vaccines are needed to reduce the disease burden of the swine industry. Induction of an effective mucosal immunity to several respiratory pathogens by direct delivery of a vaccine to mucosal sites has proven to be effective in a mouse model. However, there are challenges in eliciting mucosal immunity to PRRS due to our limited understanding of safe and potent mucosal adjuvants, which could potentiate the mucosal immune response to PRRSV. The purpose of this review is to discuss methods for induction of protective mucosal immune responses in the respiratory tract of pigs. The manuscript also discusses how PRRSV modulates innate, adaptive and immunoregulatory responses at both mucosal and systemic sites of infected and/or vaccinated pigs. This information may help in the design of innovative mucosal vaccines to elicit superior cross-protective immunity against divergent field strains of PRRSV.

2021 ◽  
Vol 52 (1) ◽  
Author(s):  
Hongfang Ma ◽  
Rui Li ◽  
Longguang Jiang ◽  
Songlin Qiao ◽  
Xin-xin Chen ◽  
...  

AbstractPorcine reproductive and respiratory syndrome (PRRS) is a serious disease burdening global swine industry. Infection by its etiological agent, PRRS virus (PRRSV), shows a highly restricted tropism of host cells and has been demonstrated to be mediated by an essential scavenger receptor (SR) CD163. CD163 fifth SR cysteine-rich domain (SRCR5) is further proven to play a crucial role during viral infection. Despite intense research, the involvement of CD163 SRCR5 in PRRSV infection remains to be elucidated. In the current study, we prepared recombinant monkey CD163 (moCD163) SRCR5 and human CD163-like homolog (hCD163L1) SRCR8, and determined their crystal structures. After comparison with the previously reported crystal structure of porcine CD163 (pCD163) SRCR5, these structures showed almost identical structural folds but significantly different surface electrostatic potentials. Based on these differences, we carried out mutational research to identify that the charged residue at position 534 in association with the one at position 561 were important for PRRSV-2 infection in vitro. Altogether the current work sheds some light on CD163-mediated PRRSV-2 infection and deepens our understanding of the viral pathogenesis, which will provide clues for prevention and control of PRRS.


2017 ◽  
Vol 58 (2) ◽  
pp. 157 ◽  
Author(s):  
V. G. PAPATSIROS (Β.Γ. ΠΑΠΑΤΣΙΡΟΣ) ◽  
C. ALEXOPOULOS (Κ. ΑΛΕΞΟΠΟΥΛΟΣ) ◽  
S. C. KYRIAKIS (Σ.Κ. ΚΥΡΙΑΚΗΣ)

The clinical manifestations of PRRS virus infection vary from subclinical to severe reproductive failure and/or respiratory disease. Severity of PRRS virus associated disease may result from interactions among factors involving differences in virulence among PRRS virus isolates, probable recombination between the different isolates that are responsible for the clinical manifestation of PRRS in the same farm, differences in concurrent infections (other viruses and bacteria) and hygiene monitoring programme. It is known that viruses and bacteria interacted and the most common model of this interaction is that pathogens bacteria complicate the lesions that are due to viruses. PRRS virus induces predisposition to Streptococcus suis in nursery age pigs and increases susceptibility to Salmonella choleraesuis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Furthermore, PRRS virus is involved in aetiology and predispose to appearance of Porcine Respiratory Disease Complex (PRDC) Postweaning Multisystemic Wasting Syndrome (PMWS) and Porcine Dermatitis and Nephropathy Syndrome (PDNS). The respiratory form of PRRS co-infection with Aujeszky' disease causes severe losses in swine herds due to respiratory problems. In cases of PRRS co-infections with other agents, the cost of pork meat production is raised from the treatments and other special management strategies. Up to date, in Greece, PRRS is appeared with the enzootic form (independendy of the season) with elevations and declines. In Greek swine industry, PRRS virus is involved as primary pathogen agent in cautions of mortality of growing/finishing pigs. During the last years, the presence of the new syndromes of PRDC, PMWS and PDNS causes additional economical losses and increases the cost of Greek pork meat production. The unpublished data of editors indicate that during last year, PRRS caused severe losses in Greek swine industry. Cases of PRRS were noticed in farms which purchased gilts or piglets without keeping out preventive facilities of biosecurity as quarantine, serology examinations etc. The syndrome was appeared with the respiratory form in growing/finishing pigs associated with severe losses, due to the entrance of «new» different isolates of PRRS virus from the purchase of gilts or piglets. It is probably that these «new» different isolates were more virulent than the preexisted isolates or/and predominated with them. In cases, where severe respiratory signs in growing/finishing pigs and no or moderate reproductive form of PRRS were noticed, it is probable that the vaccinations of sows against PRRS did not protect the growing/finishing pigs or the «new» different isolates of PRRS virus had more respiratory than reproductive tropism or coexistenced in all earlier circumstances. Today, PRRS is a dangerous risk factor for the Greek swine industry and for this reason it is important to apply all preventive facilities as: vaccinations, reduction of the introduction gilts and maintenance of a grandparent nucleus in the farm for producing gilts, quarantine and serological monitoring for all introduced animals (gilts and piglets), as well as the purchase of animals from PRRS-negative farms. The purchase of piglets has to be avoided because it induces negative effects on the clinical manifestation and control of PRRS.


2016 ◽  
Vol 2016 ◽  
pp. 1-16 ◽  
Author(s):  
Valentina Bernasconi ◽  
Karin Norling ◽  
Marta Bally ◽  
Fredrik Höök ◽  
Nils Y. Lycke

Immune protection against infectious diseases is most effective if located at the portal of entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that can induce strong protective immunity following oral, respiratory, or genital tract administration. At present, only few mucosal vaccines are found on the market, but recent technological advancements and a better understanding of the principles that govern priming of mucosal immune responses have contributed to a more optimistic view on the future of mucosal vaccines. Compared to live attenuated vaccines, subcomponent vaccines, most often protein-based, are considered safer, more stable, and less complicated to manufacture, but they require the addition of nontoxic and clinically safe adjuvants to be effective. In addition, another limiting factor is the large antigen dose that usually is required for mucosal vaccines. Therefore, the combination of mucosal adjuvants with the recent progress in nanoparticle technology provides an attractive solution to these problems. In particular, the liposome technology is ideal for combining protein antigen and adjuvant into an effective mucosal vaccine. Here, we describe and discuss recent progress in nanoparticle formulations using various types of liposomes that convey strong promise for the successful development of the next generation of mucosal vaccines.


2020 ◽  
Vol 13 ◽  
pp. 175628482093518
Author(s):  
Huimin Chen ◽  
Hongfen Li ◽  
Zhanju Liu

Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, are chronic inflammatory disorders of the gastrointestinal tract. With in-depth studies on the mechanisms of the initiation and development of IBD, increasing lines of evidence have focused on the intestinal microbiota in the pathogenesis of IBD. The imbalance between the host and intestinal microbiota induces dysregulated immune response in intestinal mucosa and plays a pivotal role in the initiation of disease and ongoing bowel destruction. This review focuses on recent advances in intestinal microbiota regulation of mucosal immune response as well as novel approaches based on intestinal microbiota alterations in the diagnosis and evaluation of therapeutic response in IBD.


2019 ◽  
Vol 216 (12) ◽  
pp. 2748-2762 ◽  
Author(s):  
Alexander N. Wein ◽  
Sean R. McMaster ◽  
Shiki Takamura ◽  
Paul R. Dunbar ◽  
Emily K. Cartwright ◽  
...  

Resident memory T cells (TRM cells) are an important first-line defense against respiratory pathogens, but the unique contributions of lung TRM cell populations to protective immunity and the factors that govern their localization to different compartments of the lung are not well understood. Here, we show that airway and interstitial TRM cells have distinct effector functions and that CXCR6 controls the partitioning of TRM cells within the lung by recruiting CD8 TRM cells to the airways. The absence of CXCR6 significantly decreases airway CD8 TRM cells due to altered trafficking of CXCR6−/− cells within the lung, and not decreased survival in the airways. CXCL16, the ligand for CXCR6, is localized primarily at the respiratory epithelium, and mice lacking CXCL16 also had decreased CD8 TRM cells in the airways. Finally, blocking CXCL16 inhibited the steady-state maintenance of airway TRM cells. Thus, the CXCR6/CXCL16 signaling axis controls the localization of TRM cells to different compartments of the lung and maintains airway TRM cells.


2019 ◽  
Vol 18 (06) ◽  
pp. 8-13
Author(s):  
Phat X. Dinh

Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically important diseases to swine industry worldwide. Due to the heterogeneity of field isolates, accurate detection of the PRRS virus is a diagnostic challenge. Recently, co-infection with NA-PRRSV, EU-PRRSV and HP-PRRSV isolates continuously increases in many countries, resulting in a significant impact on PRRSV diagnostics and disease control on farms. To facilitate rapid diagnosis and reliable discrimination of NA-PRRSV, EU-PRRSV and HP-PRRSV, a multiplex RT-PCR assay was established with three pairs of primers targeting highly conservative regions of nsp2 gene with predicted multiplex RT-PCR products of 364 bp, 161 bp and 259 bp, respectively. The primer pairs were optimized to be highly specific for PRRSV genotypes and were able to detect the target gene at the limit of 102 copies/μL for each gene. Clinical samples were used to evaluate this multiplex RT-PCR in parallel with a commercial real-time RT-PCR kit. Results showed over 95.2% (20/21 samples) agreement between the mRT-PCR and the real-time RT-PCR kit. Hence, it indicated that this multiplex RT-PCR could be useful for rapid and deferential diagnosis of NA-PRRSV, EU-PRRSV and HP-PRRSV in swine farms.


2018 ◽  
Vol 40 (2) ◽  
pp. 177-183
Author(s):  
Dao Thi Sen ◽  
Chu Hoang Ha ◽  
Nguyen Tuong Van

PRRS (Porcine reproductive and respiratory syndrome) is the most significant infectious disease currently devastating the swine industry. In order to diversify antigen sources for vaccine production to against PRRSV, co-expressing LTB and PRRSV GP5- an important structure protein GP5 of PRRSV were expressed in tobacco. Genes encoded for GP5 of PRRSV isolated from pigs infected PRRSV in Vietnam in 2010 and was constructed in plant expression vector under the control of seed specific phaseolin promoter and constitutive promoter 35S. The genes were then transferred into the C9-1 tobacco using Agrobacterium. The stable insertion of LTB-GP5genes in genomeoftransgenic tobacco was confirmed by PCR and RT-PCR. Western hybridization indicated that fused protein LTB-GP5 was successful expressed in tobacco seeds. Analysis of transgenic tobaco seeds revealed that under regulation of promoter beta-phaseolin, the level expression of GP5 was significant improved as quantified by ELISA (2.2 % of total soluble protein). This preliminary result is a foundation for expression of GP5 in seeds of other plants in the future.


Author(s):  
Loreto Gesualdo ◽  
Vincenzo Di Leo ◽  
Rosanna Coppo

Abstract The precise pathogenesis of immunoglobulin A nephropathy (IgAN) is still not clearly established but emerging evidence confirms a pivotal role for mucosal immunity. This review focuses on the key role of mucosa-associated lymphoid tissue (MALT) in promoting the onset of the disease, underlying the relationship among microbiota, genetic factors, food antigen, infections, and mucosal immune response. Finally, we evaluate potential therapies targeting microbes and mucosa hyperresponsiveness in IgAN patients.


Sign in / Sign up

Export Citation Format

Share Document